Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Stem Cell Therapy For Infertility Market Size, Value And Growth Trends Through 2030

The market for stem cell therapy in addressing infertility has experienced significant expansion lately. Projections indicate a rise from $1.87 billion in 2025 to $2.18 billion in 2026, reflecting a compound annual growth rate of 16.6%. Factors contributing to this growth historically include a higher incidence of infertility challenges, an increase in fertility clinics worldwide, breakthroughs in reproductive biology research, a growing preference for alternative infertility solutions, and the widespread adoption of assisted reproductive techniques.

Anticipate a swift expansion in the stem cell therapy for infertility market during the forthcoming years, projecting a valuation of $3.99 billion by 2030, fueled by a compound annual growth rate (CAGR) of 16.4%. This projected increase is bolstered by several key factors, including the escalating clinical confirmation of stem cell applications in treating infertility, a surge in financial backing for regenerative medicine in reproduction, a greater embrace of individualized fertility approaches, the broadening scope of clinical trials within reproductive health, and strengthened partnerships between fertility centers and academic research bodies. Prominent developments anticipated within this timeframe encompass a heightened emphasis on therapies aimed at ovarian and testicular regeneration, an increased deployment of treatments utilizing a patient’s own stem cells, deeper integration with assisted reproductive technologies, the broadening of tailored fertility treatment methodologies, and significant advancements in clinical investigations concerning reproductive regeneration.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30408&type=smp

Stem Cell Therapy For Infertility Market Growth Drivers: What Factors Are Accelerating Expansion?

Continued proliferation of infertility incidents is anticipated to be a major catalyst for the advancement of the stem cell therapy market focused on reproductive health. Infertility, defined as the failure of a couple to achieve pregnancy following at least a year of consistent, unprotected sexual activity, is increasingly prevalent. A primary driver behind this trend is the postponement of parenthood, with individuals opting for children at later stages of life. This delay leads to diminished fertility as the natural reproductive capacity wanes with age, a phenomenon particularly pronounced in women. Stem cell therapies present viable prospects for addressing infertility by facilitating the repair of compromised reproductive tissues, boosting the functionality of both ovaries and testes, and thereby increasing the likelihood of successful conception. Illustrating the scale of this issue, data from April 2023, as reported by the World Health Organization (WHO), a global intergovernmental body headquartered in Switzerland, indicates that infertility impacts roughly 17.5% of adults worldwide, translating to approximately one in six individuals, underscoring the escalating demand for accessible and effective fertility treatments. Consequently, the surge in infertility cases is poised to propel the growth of the stem cell therapy market dedicated to reproductive well-being.

Stem Cell Therapy For Infertility Market Segment Outlook: Which Categories Are Expanding The Fastest?

The stem cell therapy for infertility market covered in this report is segmented –

1) By Type: Male Infertility Treatment, Female Infertility Treatment

2) By Treatment Type: Autologous Stem Cell Therapy, Allogeneic Stem Cell Therapy, Combination Therapy

3) By Cell Source: Embryonic Stem Cells, Adult Stem Cells, Induced Pluripotent Stem Cells

4) By Application: Ovarian Insufficiency, Uterine Infertility, Genetic Disorders

5) By End User: Hospitals, Specialty Clinics, Research Institutes

Subsegments:

1) By Male Infertility Treatment: Surgical Sperm Retrieval, Hormonal Therapy, Stem Cell Transplantation, Assisted Reproductive Techniques

2) By Female Infertility Treatment: Ovarian Stem Cell Therapy, Endometrial Regeneration Therapy, Hormonal Therapy, In Vitro Fertilization Enhancement

Stem Cell Therapy For Infertility Market Trends: What Is Shaping Future Industry Growth?

In the realm of stem cell therapies for infertility, leading enterprises are dedicating their efforts to pioneering innovations in stem cell technology, particularly with induced pluripotent stem cells (iPSCs). This strategic focus aims to refine regenerative treatments tailored to individuals, bolster outcomes specific to each patient, and broaden the scope of reproductive ailments that can be addressed. Induced pluripotent stem cells function by reverting mature, specialized body cells to an undifferentiated, embryonic-like state, granting them the potential to develop into nearly any cell within the human organism. A notable development occurred in January 2025 when Gameto Inc., a biotechnology firm situated in the United States, commenced a crucial Phase III clinical investigation for Fertilo, its iPSC-based fertility treatment. This trial received approval through an Investigational New Drug (IND) application granted by the U.S. Food and Drug Administration (FDA). The study, which will involve around 15 locations throughout the U.S., is designed to assess the maturation of eggs outside the body, supported by specially developed ovarian support cells. This novel approach holds the promise of not only abbreviating the duration of in-vitro fertilization (IVF) cycles but also potentially diminishing the need for hormonal stimulation by as much as 80%. The successful conclusion of this trial would mark a significant milestone, establishing it as the inaugural late-stage clinical program for a therapy involving in-vitro egg maturation derived from induced pluripotent stem cells in the management of infertility.

Stem Cell Therapy For Infertility Market Key Companies And Competitive Benchmarking

Major companies operating in the stem cell therapy for infertility market are PlacidWay LLC, New Life India Fertility Clinic Private Limited, Jeevan Mithra Fertility Centre Private Limited, Equipo IVI S.L., Hope Fertility & Stem Cell Centre Pvt. Ltd., Bioscience Institute SpA, Advancells Dermaceuticals Private Limited, GIOSTAR INDIA PRIVATE LIMITED, Shree IVF Clinic Private Limited, Stem Cells Care (india) Private Limited, GenCell Ltd., StemRx BioScience Solutions Private Limited., Kiran Infertility Centre Private Limited, R3 Stem Cell LLC., Bavishi Fertility Institute Private Limited, Seragen Biotherapeutics Private Limited, Esha IVF Fertility Centre Private Limited, Embryonic Tissue Center EmCell, InoCells B.V., Vega Stem Cell Clinic Co. Ltd.

Access The Complete Stem Cell Therapy For Infertility Market Report:

https://www.thebusinessresearchcompany.com/report/global-stem-cell-therapy-for-infertility-market-report

Stem Cell Therapy For Infertility Market Largest Region: Which Geography Holds The Highest Market Share?

North Americawas the largest region in the stem cell therapy for infertility market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell therapy for infertility market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model